Placebo News and Research

RSS

Trial evaluates purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder

Researchers investigated the safety and pharmacokinetics of JNJ-54175446 in a double-blind, multicenter, randomized controlled trial (RCT).

31 Jul 2023

Novel vaccine targets inflamed brain cells in Alzheimer's to modify the course of disease

A novel vaccine that targets inflamed brain cells associated with Alzheimer's disease may hold the key to potentially preventing or modifying the course of the disease, according to preliminary research presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2023.

31 Jul 2023

Broad-spectrum influenza vaccine candidate shows safety, immunogenicity data across three dose levels

Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses, today announced that The Lancet Infectious Diseases published results from the company's OVX836-003 study under the title, "Immunogenicity, safety and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: randomized, double-blind placebo-controlled, Phase 2a trial."

27 Jul 2023

Kundalini yoga may be beneficial for older women with Alzheimer's risk factors

Kundalini yoga, a form of yoga that focuses on breathing, meditation, and mental visualization, appeared beneficial for older women who had risk factors for Alzheimer's disease and concerns about episodes of memory decline, according to a UCLA Health study.

26 Jul 2023

Effects of turmeric supplementation in individuals with metabolic syndrome and diabetes

Study evaluated the effects of turmeric supplementation on glucose metabolism in patients with metabolic syndrome.

26 Jul 2023

Desert olive tree pearls may alleviate cognitive problems in middle-aged and older adults

Study investigated the significant effects of desert olive tree pearls (DOTPs) on the cognitive function.

26 Jul 2023

Does a multidomain intervention of aerobic-resistance exercises with cognitive training and vitamin D improve cognition in older adults with mild cognitive impairment?

Researchers used a SYNERGIC Trial to evaluate the efficacy of a combination of cognitive training, progressive exercise, and vitamin D supplementation on reversing the effects of mild cognitive impairment in adults

26 Jul 2023

Consuming strawberries may promote cognitive function and improve cardiovascular risk factors

Daily strawberry consumption was linked to improved cognitive function, lower blood pressure and higher antioxidant capacity in a randomized clinical trial presented today at Nutrition 2023, the annual meeting of the American Society of Nutrition.

24 Jul 2023

Dealcoholized muscadine wine may improve skin elasticity

Could muscadine wine help perk up sagging skin? According to a new study, women who drank two glasses of dealcoholized muscadine wine daily showed significant improvements in the elasticity and water retention of their skin compared with those who consumed a placebo.

24 Jul 2023

Probiotic may help prevent cognitive decline during aging

Findings from a new study suggest that taking a probiotic could help prevent the decline in memory and thinking that can accompany aging.

24 Jul 2023

Donanemab: A trailblazer for Alzheimer's disease treatment?

A recent study evaluated the efficacy and side effects of donanemab, an antibody that could possibly clear brain amyloid plaque in early symptomatic Alzheimer disease (AD).

20 Jul 2023

Donanemab may offer new hope for people with early Alzheimer's disease

The data reported today by Eli Lilly from the TRAILBLAZER-ALZ 2 clinical trial of donanemab in early symptomatic Alzheimer's disease demonstrate an important advancement in Alzheimer's research and treatment.

17 Jul 2023

Donanemab shows promise in slowing Alzheimer's disease

With yet a third new Alzheimer's drug expected to be approved by the Food and Drug Administration (FDA), the field is beginning to show progress in the fight to slow the disease.

17 Jul 2023

Exploring the efficacy of topical lidocaine in individuals with chronic neck pain

A team of researchers investigated the efficacy of lidocaine for the treatment of neck pain.

17 Jul 2023

What are the effects of insect consumption on human health?

A systematic review of human studies reveals that insect proteins are as good as other protein sources in providing essential amino acids and other health benefits.

13 Jul 2023

Cytisinicline could offer adult cigarette smokers a potential new treatment option

The first large-scale U.S. clinical trial of cytisinicline, led by a Massachusetts General Hospital (MGH) investigator, found the smoking cessation medication to be effective and well tolerated in adults who wished to break their nicotine dependence.

11 Jul 2023

Biomarkers in the brain could redefine mental health conditions

The study of biomarkers in the brain - powered by cutting-edge machine learning techniques - could redefine the way mental health conditions are categorized and diagnosed and lead to more effective, personalized treatments.

10 Jul 2023

Two anti-inflammatory drugs reduce deaths in severe COVID-19 patients

Two anti-inflammatory drugs, abatacept and infliximab, reduced deaths among patients hospitalized with severe COVID-19, according to a national study led by Washington University School of Medicine in St. Louis. William G. Powderly, MD, (right) who led the large clinical trial, discusses patient conditions with Maanasi Samant, MD, in the intensive care unit at Barnes-Jewish Hospital, one of the major trial sites, during the COVID-19 pandemic.

10 Jul 2023

Lilly granted MHRA marketing authorization in Great Britain for a ground-breaking UC therapy

Eli Lilly and Company announced today that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation (MA) for mirikizumab (OMVOH®) for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.

10 Jul 2023

Moderna provides an update on regulatory submissions for RSV vaccine candidate, mRNA-1345

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided an update on regulatory submissions for mRNA-1345, a vaccine for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease (ARD) in adults aged 60 years or older.

10 Jul 2023

Placebo News and Research

Trial evaluates purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder

Novel vaccine targets inflamed brain cells in Alzheimer's to modify the course of disease

Broad-spectrum influenza vaccine candidate shows safety, immunogenicity data across three dose levels

Kundalini yoga may be beneficial for older women with Alzheimer's risk factors

Effects of turmeric supplementation in individuals with metabolic syndrome and diabetes

Desert olive tree pearls may alleviate cognitive problems in middle-aged and older adults

Does a multidomain intervention of aerobic-resistance exercises with cognitive training and vitamin D improve cognition in older adults with mild cognitive impairment?

Consuming strawberries may promote cognitive function and improve cardiovascular risk factors

Dealcoholized muscadine wine may improve skin elasticity

Probiotic may help prevent cognitive decline during aging

Donanemab: A trailblazer for Alzheimer's disease treatment?

Donanemab may offer new hope for people with early Alzheimer's disease

Donanemab shows promise in slowing Alzheimer's disease

Exploring the efficacy of topical lidocaine in individuals with chronic neck pain

What are the effects of insect consumption on human health?

Cytisinicline could offer adult cigarette smokers a potential new treatment option

Biomarkers in the brain could redefine mental health conditions

Two anti-inflammatory drugs reduce deaths in severe COVID-19 patients

Lilly granted MHRA marketing authorization in Great Britain for a ground-breaking UC therapy

Moderna provides an update on regulatory submissions for RSV vaccine candidate, mRNA-1345

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News